FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is ...
By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action ...
MiBolsilloColombia on MSN
FDA alert: Massive M&M's recall hits 20 states due to safety concerns
The FDA has announced a major recall of M&M’s candies across 20 U.S. states due to a labeling error. The affected products ...
The FDA's approval process was designed for medical devices that stay largely the same after launch. Clinical AI does not ...
The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.“These actions are ...
The labeling updates address the risk of early-onset toxicity, including life-threatening adverse events in patients with DPD ...
Built for researchers and manufacturers, the FDA’s TDSi tool enables analysis of food contaminant and nutrient trends, ...
In a pilot, Utah is testing use of AI for renewing drug prescriptions. Experts ask if it should be regulated as a medical ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
Stocktwits on MSN
Eli Lilly stock has over 20% upside, analysts say: Retail seeks pharma 'safe haven' as FDA targets GLP-1 copycats
Regulatory scrutiny around compounded GLP-1s pushed investors toward established, FDA-approved drugmakers like Lilly.
The Food and Drug Administration is reviewing the safety of the abortion pill mifepristone, Health and Human Services Secretary Robert F. Kennedy Jr. said in a recent letter to Republican state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results